Latest news and press releases about Retractable Technologies, Inc. (RVP): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader North and South American continents, and other international territories.
Price
| Price | $0.68 |
| Market Cap | $20M |
| Exchange | AMEX |
| Country | US |
Valuation Ratios
| Price / Book | 0.28 |
| EV / EBITDA | 4.20 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -4.59% |
| Return on Invested Capital | -17.62% |
| Return on Assets | -2.38% |
| Gross Margin | 1.10% |
| Operating Margin | -66.90% |
| Net Margin | -9.94% |
Related companies: CLGN · FEMY · HBIO · NRSN · NRXS · NXGL · NXL
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of RVP: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks